Purple biotech reports fourth quarter and full-year 2024 financial results

Completed successful clinical trials for cm24 and nt21 9 oncology assets , demonstrating clinical benefit s and identifying potential biomarkers

PPBT Ratings Summary

PPBT Quant Ranking